Clinical Trials Directory

Trials / Completed

CompletedNCT04344964

Endoscopy-related Phone Consultation During the COVID-19 Outbreak

Endoscopy-related Phone Consultation During the COVID-19 Outbreak: Impact on Attendance and Patient/Consultant Perspectives From a Tertiary Australian Hospital

Status
Completed
Phase
Study type
Observational
Enrollment
186 (actual)
Sponsor
Austin Health · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate patient and consultant experiences with phone consultations for endoscopy-related outpatient appointments during the COVID-19 outbreak.

Detailed description

Telephone consultations as a method for telehealth do not provide visual cues and limit interpretation of visual signs such as visualization of skin lesions. However, the need of such feedback is almost non-existent for endoscopy-related consultations as their purpose is focused. The main foci of endoscopy-related outpatient clinics are two: 1 - inform and consent the patient for an endoscopic procedure that is to be done in the near future; 2 - explain the results of a recent procedure already performed and which has a copy provided to the patient. Therefore, phone consultations might be a good fit for endoscopy-related outpatient clinics. The practicalities and indications for the use of phone consults has been described by van Galen \& Car (2018) and fit the above description. Patients will be invited to participate only after the consultation have been finalised and all questions regarding the endoscopic procedure to be done/that was done have been clarified. Patients and consultants will fill questionnaires to evaluate the phone consultation. The primary outcome will the the comparison of "failed to attend" (FTA) occurrences compared to a similar period of the past year. Secondary outcomes will be patients' and consultants' satisfaction with the phone consultation.

Conditions

Interventions

TypeNameDescription
OTHERNone - NAObservational study

Timeline

Start date
2020-04-15
Primary completion
2020-05-29
Completion
2020-07-03
First posted
2020-04-14
Last updated
2020-07-09

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT04344964. Inclusion in this directory is not an endorsement.